第11章 臨床市場動向分析

第12章 企業プロファイル

第13章 結論

図表

目次

Product Code: BIO135A

REPORT HIGHLIGHTS

The global market for induced pluripotent stem cells (iPSCs) was estimated to
total $853 million in 2012, and close to $1.2 billion in 2013, averaging 40%
growth. The market is expected to reach $2.9 billion in 2018, an estimated
compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to
2018.

This report provides:

An overview of the global market for induced pluripotent stem cells.

Analyses of global market trends, with data from 2012 and 2013, and
projections of CAGRs through 2018.

Information on induced pluripotent stem cell research products, defined as
all research tools including but not limited to: induced pluripotent stem
cells and various differentiated cells derived from induced pluripotent stem
cells, various related assays and kits, culture media and medium components
such as serum, growth factors and inhibitors, antibodies, enzymes, and many
others that can be applied for the specific purpose of executing induced
pluripotent stem cell research.

Discussion of important manufacturers, technologies, and factors
influencing market demand such as the driving forces and limiting factors of
induced pluripotent stem cell market growth.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market and industry analyses to
help readers quantify and qualify the global market for induced pluripotent
stem cells (iPSCs). Important trends of the field and market segments are
identified, and market sizes and sales forecasts by segmented markets are
provided through 2018.

This report focuses on the market side rather than the technical side. The
detailed market segmentation, market shares, major drivers, trend analysis and
forecasts for the entire iPSCs market are analyzed.

REASONS FOR DOING THIS STUDY

Detailed market and industry analysis for the iPSCs market is needed. As a
breakthrough technology recognized by 2012 Nobel Physiology and Medicine
Prize, iPSCs technology may bring a revolutionary change to modern medicine.
Great opportunities always exist with high risks, but the detailed analysis
and forecasts of the iPSC market can provide useful information for all
management levels to help make strategic decisions in related areas.

iPSC-related products are forming an emerging market despite the fact that
iPSC clinical applications are still under development. The potential scope of
the iPSC market is becoming clear, and it is appropriate to review the
emerging market, see the current size and share of each segment, evaluate the
market trends and look to its future.

SCOPE OF REPORT

This study is focused on the market side of iPSCs rather than its technical
side. Different market segments for this emerging market are covered. For
example, application-based market segments include academic research, drug
development and toxicity testing, and regenerative medicine; product
function-based market segments include molecular and cellular engineering,
cellular reprogramming, cell culture, cell differentiation, and cell analysis;
iPSC-derived cell-type-based market segments include cardiomyocytes,
hepatocytes, neurons, endothelia cells, and other cell types; geography-based
market segments include the U.S., Europe, Asia-Pacific and Rest of World.
Research and market trends are also analyzed by analyzing the funding, patent
publications and sales trends of major players in the field.

ANALYST CREDENTIALS

Mike Fan has more than 20 years experience in biotech research and
development (R&D) and life science marketing from academics and industry. Dr.
Fan has a broad range of experience in chemical, biochemical and biomedical
areas, including biochemical engineering (e.g., microbial fermentation,
biocatalysis, metabolic engineering), chemical synthesis, biomedical
engineering (e.g., biomedical instrument development, microarray
technologies), molecular genetics, genetic analysis, drug discovery, cancer
biology, cancer immunology, targeted therapy and stem cell research. He holds
a PhD in Chemical Engineering and a Master of Business Administration focusing
on Marketing.